Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) Short Interest Update

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) was the recipient of a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 81,000 shares, a drop of 48.1% from the March 31st total of 156,200 shares. Approximately 0.5% of the company’s shares are sold short. Based on an average daily volume of 69,200 shares, the short-interest ratio is presently 1.2 days.

Sensei Biotherapeutics Trading Up 2.0 %

Shares of SNSE traded up $0.02 during trading hours on Friday, reaching $1.02. 6,161 shares of the company traded hands, compared to its average volume of 92,672. Sensei Biotherapeutics has a 12 month low of $0.51 and a 12 month high of $1.72. The company has a market capitalization of $25.57 million, a price-to-earnings ratio of -0.84 and a beta of 0.17. The company’s fifty day moving average price is $0.97 and its two-hundred day moving average price is $0.81. The company has a quick ratio of 11.92, a current ratio of 11.92 and a debt-to-equity ratio of 0.01.

Sensei Biotherapeutics (NASDAQ:SNSE) last posted its earnings results on Wednesday, February 28th. The company reported ($0.30) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.32) by $0.02. Equities research analysts predict that Sensei Biotherapeutics will post -0.97 earnings per share for the current fiscal year.

Sensei Biotherapeutics Company Profile

Sensei Biotherapeutics, Inc, an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. The company's Tumor Microenvironment Activated Biologics platform is designed to generate highly selective therapeutics that disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment.